Regional Blood Flow Dynamics in Response to Insulin and IGF-1 in Diabetic Animals

References

• Stamler J., Vaccaro O., Neaton J. D., Wentworth D. Diabetes, other risk factors, and 12 yr. cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993; 16: 434–444
   Google Scholar
• Tooke J. E. Microvascular hemodynamics in diabetes. Clin. Sci. 1986; 70: 119–125
   PubMed Web of Science ®Google Scholar
• Dubrey S. W., Reaveley D. R., Seed M., Lane D. A., Ireland H., O'Donnel M., O'Connor B., Noble M. I., Leslie R. D. Risk factors for cardiovascular disease in IDDM. A study of identical twins. Diabetes 1994; 43: 831–835
   Google Scholar
• Kannel W. B., McGee D. L. Diabetes and cardiovascular disease: the framinyham study. J. Amer. Med. Assoc. 1979; 241: 2035–2038
   PubMed Web of Science ®Google Scholar
• Pirart J. Diabetes mellitus and its degenerative complications: A prospective study of 4400 patients observed between 1947 and 1973. Diabet. Metab. 1977; 3: 97–107
   Google Scholar
• Wright-Richey J., Schultz-Klarr S., Dunbar J. C. The effect of ventral medial hypothalamic lesion on the insulin-induced hypotensive response in normal rats. Acta Diabetol. 1994; 31: 91–97
   PubMed Web of Science ®Google Scholar
• Schultz-Klarr S., Wright-Richey J., Dunbar J. C. The effect of insulin-induced hypoglycemia, 2-deoxyglucose-induced glucopenia and hyperglycemia on cardiovascular tone in normal and diabetic rats. Diab. Res. Clin. Pract. 1994; 26: 81–89
   PubMed Web of Science ®Google Scholar
• Pete G., Hu Y., Walsh M. F., Sowers J., Dunbar J. C. IGF-1 decreases mean blood pressure and selectively increases regional blood flow in normal rats. Proc. Soc. Biol. Med. 1996; 213: 186–191
   Google Scholar
• Baron A. D. Hemodynamic actions of insulin. Am. J. Physiol. 1994; 267: E187–E202
   PubMed Web of Science ®Google Scholar
• Anderson E. A., Mark A. L. The vasodilator action of insulin. Implication for the insulin hypothesis of hypertension. Hypertension 1993; 21: 136–141
   PubMed Web of Science ®Google Scholar
• Lembo G., Rendina V., Iaccarino G., Lamenza F., Volpe M., Trimarco B. Insulin reduces reflex foreman sympathetic vasoconstriction in healthy humans. Hypertension 1993; 21: 1015–1019
   PubMed Web of Science ®Google Scholar
• Hirschberg R., Kopple J. Evidence that insulin-like growth factor 1 increases renal plasma flow and glomerular filtration rate in fasted rats. J. Clin. Invest. 1989; 83: 326–330
   PubMed Web of Science ®Google Scholar
• Wu H., Jeny Y. Y., Yue C., et al. Endothelial dependent vascular effects of insulin and insulin-like growth factor 1 in the perfused rat mesenteric artery and aortic ring. Diabetes 1994; 43: 1027–1032
   PubMed Web of Science ®Google Scholar
• Walsh M. F., Barazi M., Pete G., Muniyappa R., Dunbar J. C., Sowers J. R. IGF-1 diminishes in vivoand in vitrovascular contractility: Role of vascular nitric oxide. Endocrinology 1996; 137: 1798–1803
   PubMed Web of Science ®Google Scholar
• Laakso M. S., Edelman S. V., Brechtel G., Baron A. D. Impaired insulin mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 1992; 41: 1076–1083
   PubMed Web of Science ®Google Scholar
• Usala A. L., Madigan T., Burquera B., Cefalu W., Sinha M. K., Powell J. G., Usala S. J. High dose intravenous but not low dose subcutaneous insulin-like growth factor-1 therapy induces substained insulin sensitivity in severely resistant Type 1 diabetes mellitus. J. Clin. Endocrin. Metab. 1994; 79: 435–440
   PubMed Web of Science ®Google Scholar
• Reaven G. M., Chang H. Relationship between blood pressure, insulin concentration and insulin action in SHR and WKY rats. Amer. J. Hypertens. 1991; 4: 34–38
   PubMed Web of Science ®Google Scholar
• Reaven G. M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607
   PubMed Web of Science ®Google Scholar
• Cooper M. E., Rumble J., Komers R., He-Cheng D., Jandeleit K. Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition. Diabetes 1994; 43: 1221–1228
   PubMed Web of Science ®Google Scholar
• Jandeleit K., Rumble J., Jackson B., Cooper M. E. Mesenteric vascular angiotensin-converting enzyme is increased in experimental diabetes mellitus. Clin. Exp. Pharmacol. Physiol. 1992; 19: 343–347
   PubMed Web of Science ®Google Scholar
• Schultz-Klarr S., Wright-Richey J., Dunbar J. C. The effect of intracerebroventricular administration of insulin, 2-deoxyglucose and glucose on metabolic and cardiovascular responses. JAAMP 1994; 5: 152–158
   Google Scholar
• Hickner R. C., Ungerstedt U., Henriksson J. Regulation of skeletal muscle blood flow during acute insulin-induced hypoglycemia in the rat. Diabetes 1994; 43: 1340–1344
   PubMed Web of Science ®Google Scholar
• Tomiyama H., Abeta T., Kurumatani H., Taguchi H., Kuga N., Saito F., Kobayashi F., Otsuka Y., Kanmatsuse K., Kajiwara N. Blood pressure response to hyperinsulinemia in salt-sensitive and salt resistant rats. Hypertension 1992; 20: 596–600
   PubMed Web of Science ®Google Scholar
• Wang Y., Brooks D. P., Edwards R. M. Attenuated glomerular cGMP production and renal dilation in streptozotocin-induced diabetic rats. Amer. J. Physiol. 1993; 264: R952–R956
   PubMed Web of Science ®Google Scholar
• Kiff R. J., Gardiner S. M., Compton A. M., Bennett T. Selective impairment of hind quarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus. Br. J. Pharmacol. 1991; 103: 1357–1362
   PubMed Web of Science ®Google Scholar
• Steinberg H. O., Brechtel G., Johnson A., Fineberg N., Baron A. D. Insulin mediates skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J. Clin. Invest. 1994; 94: 1172–1179
   Google Scholar
• Diez J., Ruilope L. M., Rodicio J. L. Insulin-like growth factor 1 a determinant of renal hemodynamics in obese hypertension. J. Hypertension 1993; 11: 5192–5193
   Google Scholar
• Allen T. J., Cooper M. E., O'Brien R. C., Bach L. A., Jackson B., Jerums G. Glomerular filtration rate in the streptozotocin diabetic rat: The role of exchangable sodium, vasoactive hormones, and insulin therapy. Diabetes 1990; 39: 1182–1190
   PubMed Web of Science ®Google Scholar
• Wiseman M., Veberti G. C. Kidney size and glomerular filtration rate in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1983; 25: 530
   PubMed Web of Science ®Google Scholar
• Tolins J. P., Shultz P.j., Raij L., Brown D. M., Mauer S. M. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: Role of NO. Amer. J. Physiol. 1993; 265: F886–F895
   PubMed Web of Science ®Google Scholar